Bernhard Hering, MD
Executive Director, Schulze Diabetes Institute
Contact Info
Executive Director, Schulze Diabetes Institute
Professor, Department of Surgery
Research Chair, Islet Cell Transplantation Program Eunice L. Dwan Diabetes
M.D., Justus-Liebig-University, Giessen, Germany, 1983
Residency, Justus-Liebig-University, Giessen, Germany, 1985-1995 (Internal Medicine)
Fellowship, Justus-Lieb-University, Giessen, Germany, 1995-1996 (Endocrinology)
Summary
Dr. Hering is internationally renowned for his expertise in islet cell transplantation. His research focuses on finding innovative cell-based therapies to restore blood glucose control and insulin independence for people with type 1 diabetes. Additionally, he is committed to exploring new sources of islet cells through xenotransplantation. He is the medical director of the Collaborative Islet Transplant Registry (CITR), and has also served as president of the Cell Transplant Society and as councilor of the International Pancreas and Islet Transplant Association. Dr. Hering also serves on steering committees of major clinical research programs in transplantation and diabetes such as the National Institutes of Health (NIH) Immune Tolerance Network, the Type 1 Diabetes TrialNet, and the Clinical Islet Transplant Consortium, which is the largest ever funded research activity in islet transplantation
Expertise
- Diabetes
- Islet transplantat
- Pancreatectomy and auto islet transplant
- solid organ transplant
Professional Associations
Past-President of the International Pancreas and Islet Transplant Association
Past-President of the International Xenotransplantation Association
Research
Research Summary/Interests
Cell Biology and Immunobiology of Islet Transplantation in Preclinical Models
Clinical
Clinical Interests
Islet Transplantation for Treatment of Type I Diabetes